The Journal Authors Editorial board Browse archive First online

Journal of APPLIED BIOMEDICINE on-line

EISSN 1214-0287; ISSN 1214-021X
Founded: 2003 by Josef Berger
Abbreviated title: J Appl Biomed

Providing a unique perspective, this international journal publishes peer-reviewed original papers and reviews offering a transfer of basic research to applied biomedicine.

The Journal of Applied Biomedicine promotes the translation of basic biomedical research into clinical investigation, the conversion clinical evidence into practice, and the publication of new ideas for conquering human health problems across disciplines. It is a quarterly journal. It receives research papers from Europe and overseas.

Published by the Faculty of Health and Social Studies, University of South Bohemia, Ceske Budejovice, Czech Republic
All articles in Journal of Applied Biomedicine on line are available free, and access to research articles is barrier-free.


Editor-in-Chief: Josef Berger
Co-Editor: Jiri Patocka
Co-Editor: Karel Smetana
Executive Editor: Zdenek Chval

Managing Editor: Valerie Tothova
Editorial Assistant: Zuzana Strakova
Language Editor: John P. McAvoy

Editorial board:
Josef Berger (University of South Bohemia, Ceske Budejovice, CZ, comparative pathology)
Jan Bubenik (Institute of Molecular Genetics, Praha, CZ,molecular immunology)
Nicolas Cermakian (Douglas Mental Health University Institute, Montreal, CA, molecular chronomedicine)
Germaine Cornelissen (University of Minnesota, Minneapolis, USA, chronomics)
Peter Eckl (University of Salzburg, Salzburg, A, cellular medicine)
Laurent Frossard (University of Quebec, Montreal, CA, applied biomechanics)
Monica De la Fuente (Complutense University, Madrid, E, cellular gerontology)
Herwig O. Gutzeit (Institute of Zoology, Dresden, D, reproductive biology)
Josef Havel (Masaryk University, Brno, CZ, bioanalytical chemistry)
Chi-Tang Ho (Rutgers University, New Brunswick, USA, food chemistry)
Roman Kubec (University of South Bohemia, Ceske Budejovice, CZ, chemistry of natural proucts)
Kamil Kuca (University of Defense, Hradec Kralove, CZ, experimental toxicology)
Milena Kralickova (Charles University, Plzen, CZ, developmental medicine)
David Lloyd (University of Cardiff, UK, microbiology)
Mirek Macka (University of Tasmania, AUS, analytical bioengineering)
Francisco Javier Medina Diaz (Centre of Biological Studies, Madrid, E, cytology)
Ali Mobasheri (University of Nottingham, UK, proteomics)
Rabi Ann Musah (State University of New York, Albany, USA, protein biochemistry)
Michal Opas (University of Toronto, CA, pathobiology)
Andre Nieoullon (CNRS, Marseille, F, neuroscience)
Jiri Patocka (University of South Bohemia, Ceske Budejovice, CZ, general toxicology)
Carlo E. Pellicciari (University of Pavia, Pavia, I, cytochemistry)
Eladia Maria Pena Mendez (University of La Laguna, Tenerife, E, environmental chemistry)
Georg A. Petroianu (Florida International University, Miami, USA, clinical toxicology)
Roman Prymula (University Hospital, Hradec Kralove, CZ, vaccinology)
Ana Beatriz Rodriguez Moratinos (University of Extremadura, Badajoz, E, comparative physiology)
David Rubinsztein (University of Cambridge, UK, medical genetics)
Andrzej Skladanowski (Gdansk University of Technology, PL, cell pharmacology)
Krystyna Skwarlo-Sonta (University of Warsaw, PL, molecular chronobiology)
Karel Smetana (Institute of Haematology and Blood Transfusion, Praha, CZ, cell pathology)
George B. Stefano (State University of New York, Old Westbury, USA, neuroimmunology)
Gunter Vollmer (Technical University, Dresden, D, endocrinology)
Yehiel Zick (Weizmann Institute of Science, Rehovot, IL, cell signalling)
Friedo Zoelzer (University of South Bohemia, Ceske Budejovice, CZ, radiology)